Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 57,877 | 36,275 | 52,121 | 33,053 | 57,994 |
| Gross Profit | 57,877 | 36,275 | 52,121 | 33,053 | 57,994 |
| Operating Expenses | 592,140 | 551,566 | 510,285 | 300,903 | 194,577 |
| Operating Income | -534,263 | -515,291 | -458,164 | -267,850 | -136,583 |
| Other Income | 15,242 | 34,099 | -16,022 | -42 | 2,352 |
| Pre-tax Income | -519,021 | -481,192 | -474,186 | -267,892 | -134,231 |
| Net Income Continuous | -519,021 | -481,192 | -474,186 | -267,892 | -134,231 |
| Net Income | $-519,021 | $-481,192 | $-474,186 | $-267,892 | $-134,231 |
| EPS Basic Total Ops | -5.25 | -5.42 | -6.16 | -3.78 | -2.40 |
| EPS Basic Continuous Ops | -5.25 | -5.42 | -6.16 | -3.78 | -2.40 |
| EPS Diluted Total Ops | -5.25 | -5.42 | -6.16 | -3.78 | -2.40 |
| EPS Diluted Continuous Ops | -5.25 | -5.42 | -6.16 | -3.78 | -2.40 |
| EPS Diluted Before Non-Recurring Items | -4.92 | -5.42 | -6.16 | -3.78 | -2.40 |
| EBITDA(a) | $-523,978 | $-506,315 | $-450,592 | $-260,959 | $-130,272 |